C’elle Stem Cell Innovation for Women
Are you looking for some unique meaningful gift for someone you love? Think about this new stem cell research innovation, C’elle, harvested from menstrual fluid. Many people think this is controversial, but The C’elle stem cell is non-controversial.This is also highly proliferative. It can also transform into many other stem cell types such as cardiac, neural and bone. A scientific stem cell research study on menstrual stem cells was recently published in the highly respected peer-reviewed scientific journal of Cell Transplantation. C’elle is in three pre-clinical (non-human)stem cell research studies. C’elle may have significant potential for future human stem cell therapies to possibly treat life affecting disorders such as diabetes; stroke and heart disease as well as possible anti-aging, burn and wound healing therapies. Women can now invest in future potential health care and well-being by ordering C’elle today for an affordable limited-time introductory price. Stem cell research has determined that C’elle is a 100% match for the woman donor and may possibly match her first-degree relatives such as a parent, sibling or child. The time for C’elle is now while a woman’s body is healthy and disease-free. Visit http://www.celle.com to order online. Here thay have clearly explained about the c’elle process works. You can read about the benefits of c’elle and also can learn why you need to subscribe to c’elle. C’elle’s exclusive and revolutionary service provides women with the unique opportunity to collect and preserve vital stem cells that can be harvested from the body’s menstrual fluid during the menstrual cycle.Until now, menstrual blood has typically been discarded as unsanitary waste.This is more useful besides that it gives you lot of knowledge and information. Just check out this site. Its really interesting.
Did you enjoy this post? Why not leave a comment below and continue the conversation, or subscribe to my feed and get articles like this delivered automatically to your feed reader.
Comments
No comments yet.
Leave a comment